Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hofer

Showing results (441-450 of 454) with videos related to

Pageof 46
Sort By:
JCO Oncology Practice|June 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted AnalysisGarth W Strohbehn, Molly C Tokaz, Daniel Sanghoon Shin, et al.
JAMA Network Open|January 15, 2021
A Method to Quantify Mean Hypertension Treatment Daily Dose Intensity Using Health Care System DataLillian Min, Jin-Kyung Ha, Carole E Aubert, et al.
Translational Lung Cancer Research|August 12, 2022
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker studyLukas Käsmann, Julian Taugner, Chukwuka Eze, et al.
JAMA|June 5, 2023
Germline Genetic Testing After Cancer DiagnosisAllison W Kurian, Paul Abrahamse, Allison Furgal, et al.
The Lancet. Oncology|May 31, 2024
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health systemAlex K Bryant, Jacqueline R Lewy, R Daniel Bressler, et al.
American Journal of Respiratory and Critical Care Medicine|July 26, 2018
Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary FibrosisAina Martin-Medina, Mareike Lehmann, Olivier Burgy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate CancerSean R Miller, Dana H Chung, Rachel T Gonzalez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 3, 2025
Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care SystemSean R Miller, Rachel Tucker Gonzalez, William C Jackson, et al.
The Review of Scientific Instruments|August 3, 2021
Multi-energy reconstructions, central electron temperature measurements, and early detection of the birth and growth of runaway electrons using a versatile soft x-ray pinhole camera at MSTL F Delgado-Aparicio, P VanMeter, T Barbui, et al.
The European Respiratory Journal|June 29, 2023
Antiviral CD8<sup>+</sup> T-cell immune responses are impaired by cigarette smoke and in COPDJie Chen, Xinyuan Wang, Adrian Schmalen, et al.
Pageof 46

Showing results (441-450 of 454) with videos related to

Sort By:
Pageof 46
JCO Oncology Practice|June 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted AnalysisGarth W Strohbehn, Molly C Tokaz, Daniel Sanghoon Shin, et al.
JAMA Network Open|January 15, 2021
A Method to Quantify Mean Hypertension Treatment Daily Dose Intensity Using Health Care System DataLillian Min, Jin-Kyung Ha, Carole E Aubert, et al.
Translational Lung Cancer Research|August 12, 2022
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker studyLukas Käsmann, Julian Taugner, Chukwuka Eze, et al.
JAMA|June 5, 2023
Germline Genetic Testing After Cancer DiagnosisAllison W Kurian, Paul Abrahamse, Allison Furgal, et al.
The Lancet. Oncology|May 31, 2024
Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health systemAlex K Bryant, Jacqueline R Lewy, R Daniel Bressler, et al.
American Journal of Respiratory and Critical Care Medicine|July 26, 2018
Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary FibrosisAina Martin-Medina, Mareike Lehmann, Olivier Burgy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate CancerSean R Miller, Dana H Chung, Rachel T Gonzalez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 3, 2025
Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care SystemSean R Miller, Rachel Tucker Gonzalez, William C Jackson, et al.
The Review of Scientific Instruments|August 3, 2021
Multi-energy reconstructions, central electron temperature measurements, and early detection of the birth and growth of runaway electrons using a versatile soft x-ray pinhole camera at MSTL F Delgado-Aparicio, P VanMeter, T Barbui, et al.
The European Respiratory Journal|June 29, 2023
Antiviral CD8<sup>+</sup> T-cell immune responses are impaired by cigarette smoke and in COPDJie Chen, Xinyuan Wang, Adrian Schmalen, et al.
Pageof 46